Patents Assigned to CAPELLA BIOSCIENCE LTD
  • Antigen binding molecules that bind light
    Patent number: 11827673
    Abstract: The present invention relates antigen binding molecules, particularly antibodies, fragments and variants thereof, that bind to the TNF-related cytokine LIGHT (TNFSF14), competing with LIGHT binding to cellular receptors Herpes virus entry mediator (HVEM) and lymphotoxin beta receptor, and the use of said antigen binding molecules in treating and/or preventing inflammatory disorders and immune disorders.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: November 28, 2023
    Assignee: CAPELLA BIOSCIENCE LTD
    Inventor: Steve Holmes
  • ANTIGEN BINDING MOLECULES THAT BIND LIGHT
    Publication number: 20210284747
    Abstract: The present invention relates antigen binding molecules, particularly antibodies, fragments and variants thereof, that bind to the TNF-related cytokine LIGHT (TNFSF14), competing with LIGHT binding to cellular receptors Herpes virus entry mediator (HVEM) and lymphotoxin beta receptor, and the use of said antigen binding molecules in treating and/or preventing inflammatory disorders and immune disorders.
    Type: Application
    Filed: January 24, 2018
    Publication date: September 16, 2021
    Applicant: CAPELLA BIOSCIENCE LTD
    Inventor: Steve HOLMES